Previous Article | Next Article ![]()
J. Virol., 03 1996, 1804-1809, Vol 70, No. 3
AD Miller, L Bonham, J Alfano, HP Kiem, T Reynolds and G Wolgamot
An important requirement for the use of retroviral vectors in human gene
transfer experiments is the avoidance of human exposure to
replication-competent (helper) retroviruses. To meet this requirement, we
used a sensitive marker rescue assay for helper virus to screen
vector-transduced cells prior to reinfusion into patients. This assay
utilized Mus dunni cells harboring a retroviral vector that can be rescued
by helper retroviruses. The assay indicated the presence of helper virus in
medium exposed to hematopoietic cells from all patients tested, including
six patients with various cancers and one patient with Gaucher's disease,
whether or not the patient cells had been exposed to retroviral vectors.
All of the helper viruses were in a single interference group. We have now
shown that treatment of the M. dunni marker rescue assay cells with
5-iodo-2'-deoxyuridine or hydrocortisone can activate production of an
apparently identical helper virus, which we have named M. dunni endogenous
virus (MDEV). Thus, production of virus in the assays of patient materials
was likely due to exposure of the marker rescue assay cells to the
hydrocortisone present in the hematopoietic cell growth medium. MDEV does
not belong to any of the known murine leukemia virus groups by interference
analysis, and we have called the new group multitropic because of the wide
range of cells from different species that MDEV can infect.
Copyright © 1996, American Society for Microbiology
A novel murine retrovirus identified during testing for helper virus in human gene transfer trials
Fred Hutchinson Cancer Research Center, University of Washington, Seattle 98109, USA. dmiller@fred.fhcrc.org
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|